Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocept Inc (BIOC)
NASDAQ:BIOC
Biocept (BIOC) Stock Price & Analysis
1,249 Followers
BIOC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.80 - $28.52
Previous Close$1.35
Volume64.86K
Average Volume (3M)1.91M
Market Cap
$3.55M
Enterprise ValueN/A
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$11.06M
Price to Earnings (P/E)>-0.1
Beta0.82
Next Earnings
Nov 15, 2023EPS Estimate
-$2.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-39.28
Shares Outstanding2,626,026
10 Day Avg. Volume316,756
30 Day Avg. Volume1,908,683
Standard Deviation0.36
R-Squared0.02
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)12.22
Price to Sales (P/S)6.04
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Biocept News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BIOC FAQ
What was Biocept Inc’s price range in the past 12 months?
Biocept Inc lowest stock price was $0.80 and its highest was $28.52 in the past 12 months.
What is Biocept Inc’s market cap?
Currently, no data Available
When is Biocept Inc’s upcoming earnings report date?
Biocept Inc’s upcoming earnings report date is Nov 15, 2023 which is in 46 days.
How were Biocept Inc’s earnings last quarter?
Biocept Inc released its earnings results on Aug 14, 2023. The company reported -$3.5 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.5.
Is Biocept Inc overvalued?
According to Wall Street analysts Biocept Inc’s price is currently Overvalued.
Does Biocept Inc pay dividends?
Biocept Inc does not currently pay dividends.
What is Biocept Inc’s EPS estimate?
Biocept Inc’s EPS estimate is -$2.36.
How many shares outstanding does Biocept Inc have?
Biocept Inc has 2,626,026 shares outstanding.
What happened to Biocept Inc’s price movement after its last earnings report?
Biocept Inc reported an EPS of -$3.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.636%.
Which hedge fund is a major shareholder of Biocept Inc?
Among the largest hedge funds holding Biocept Inc’s share is Hussman Strategic Advisors Inc. It holds Biocept Inc’s shares valued at N/A.
---
Biocept Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bearish
BIOC Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 2.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 2.9%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-61.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Biocept Inc
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding BIOC
iShares Core S&P Total U.S. Stock Market ETF
$8.10
Up to five ETFs with an Outperform Smart Score that hold BIOC. The ETFs are listed according to market value of BIOC within the ETF
---